Literature DB >> 35991743

Intraventricular neurocysticercosis causing obstructing hydrocephalus.

Alejandro Perez1, Gaurav Syngal2, Samreen Fathima3, Sam Laali4, Sadat Shamim5.   

Abstract

Neurocysticercosis is a parasitic infection caused by the larval stage of the pork tapeworm Taenia solium. Diagnostic criteria for neurocysticercosis are based on clinical manifestations, neuroimaging findings, and epidemiologic exposure. Treatment is tailored to acute symptoms. If increased intracranial pressure is present, then surgical intervention and/or corticosteroids may be used. If seizures are present, then antiepileptic drugs are used for therapy. Antiparasitic therapy is warranted for patients with viable and/or degenerating cysts in the brain parenchyma on neuroimaging. We present a case report of neurocysticercosis causing obstructive hydrocephalus requiring a ventriculoperitoneal shunt.
Copyright © 2022 Baylor University Medical Center.

Entities:  

Keywords:  Helminthic infection; Taenia solium; hydrocephalus; intraventricular neurocysticercosis; seizures

Year:  2022        PMID: 35991743      PMCID: PMC9373744          DOI: 10.1080/08998280.2022.2075669

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  13 in total

Review 1.  Hydrocephalus in Neurocysticercosis: Challenges for Clinical Practice and Basic Research Perspectives.

Authors:  Pedro Tadao Hamamoto Filho; Marco Antônio Zanini; Agnès Fleury
Journal:  World Neurosurg       Date:  2019-03-15       Impact factor: 2.104

Review 2.  Neurocysticerosis: An Individualized Approach.

Authors:  Christina M Coyle
Journal:  Infect Dis Clin North Am       Date:  2019-03       Impact factor: 5.982

3.  Neurocysticercosis in Houston, Texas: an update.

Authors:  Jose A Serpa; Edward A Graviss; Joseph S Kass; A Clinton White
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

4.  Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India.

Authors:  V Rajshekhar; M Venkat Raghava; V Prabhakaran; A Oommen; J Muliyil
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

5.  Bruns syndrome caused by intraventricular neurocysticercosis treated using flexible endoscopy.

Authors:  Jaime Torres-Corzo; Roberto Rodriguez-della Vecchia; Leonardo Rangel-Castilla
Journal:  J Neurosurg       Date:  2006-05       Impact factor: 5.115

Review 6.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

7.  Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.

Authors:  Hector H Garcia; Isidro Gonzales; Andres G Lescano; Javier A Bustos; Mirko Zimic; Diego Escalante; Herbert Saavedra; Martin Gavidia; Lourdes Rodriguez; Enrique Najar; Hugo Umeres; E Javier Pretell
Journal:  Lancet Infect Dis       Date:  2014-07-03       Impact factor: 25.071

8.  A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis.

Authors:  Héctor H Garcia; E Javier Pretell; Robert H Gilman; S Manuel Martinez; Lawrence H Moulton; Oscar H Del Brutto; Genaro Herrera; Carlton A W Evans; Armando E Gonzalez
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

Review 9.  Antiepileptic drugs for seizure control in people with neurocysticercosis.

Authors:  Dean Walton; Hannah Castell; Ceryce Collie; Greta Karen Wood; Monika Sharma; Tejinder Singh; Benedict D Michael
Journal:  Cochrane Database Syst Rev       Date:  2021-11-01

10.  Intraventricular Neurocysticercosis: Experience and Long-Term Outcome from a Tertiary Referral Center in the United States.

Authors:  Theodore E Nash; JeanAnne M Ware; Siddhartha Mahanty
Journal:  Am J Trop Med Hyg       Date:  2018-04-19       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.